Beam stock

Private-market facts for current and former Beam employees researching their stock.

Latest Round
Series E
Valuation
$1B
Founded
2012
Headquarters
Columbus, OH
Founders
Alex Frommeyer, Alex Haggart, Seth Catalli
Status
private

Talk to a Beam stock specialist

Get personalized guidance on your Beam shares — including current market activity, pricing context, and liquidity options.

Speak with an expert

Overview

Beam Benefits is a digital-first employee benefits company offering dental, vision, life, and disability insurance, using technology and smart toothbrushes to lower premiums based on oral health habits.

Beam outlook

Equity outlook85% data confidence
1x
Base scenario
2x
Upside scenario

For employees evaluating Beam equity, a 1x base multiple suggests the stock may be close to fairly valued at current prices. The upside scenario at 2x is relatively close to the base case, suggesting more predictable but narrower range of outcomes.

These estimates reflect modeled return scenarios, not guaranteed outcomes. Actual results depend on company performance, market conditions, share class, and timing.

Illustrative model · v1.0.0 · Not investment advice

Selling Beam shares

Why shareholders consider selling

Shareholders in Beam may explore liquidity for a number of reasons — diversifying a concentrated position, funding a personal financial goal, or simply reducing exposure to a single private holding. As a private company, Beam does not trade on a public exchange, meaning employees and early shareholders cannot simply sell through a brokerage. Extended private timelines can leave shareholders waiting years for an exit event, which is why some choose to explore secondary-market options.

Can you sell Beam stock?

Whether a shareholder can sell typically depends on what they hold and how it was acquired. Vested and exercised shares are generally more straightforward than unexercised options or unvested RSUs. Most private companies, including those in the Fintech sector, impose transfer restrictions such as rights of first refusal or board approval requirements. The specific terms governing Beam shares would be outlined in the holder's equity agreement or the company's governing documents.

What affects the value of Beam shares?

The price a buyer is willing to pay for private shares is shaped by several factors: overall demand for the stock, the company's financial performance, broader Fintech market conditions, and any recent private-market transaction activity. Data points such as the company's Series E round and its reported $1B valuation can help frame expectations, though they do not guarantee a transaction price.

What should holders check before selling

  • The type of security held (common shares, preferred, options, RSUs)
  • Whether the equity is fully vested and, for options, whether it has been exercised
  • Any transfer restrictions, lock-up provisions, or company approval requirements
  • Estimated net proceeds after applicable taxes and transaction fees
  • Whether partial liquidity — selling a portion rather than the full position — may be a better fit

Tools for Beam shareholders

Exploring equity in Beam often raises questions about taxes, exercise timing, valuation, and exit outcomes. These tools can help you model different decisions using your own assumptions.

Latest funding round

Beam most recently raised a Series E round . The company was valued at $1B. Total funding raised to date is approximately $175M.

Founders & company background

Beam was founded in 2012 by Alex Frommeyer, Alex Haggart, Seth Catalli and is headquartered in Columbus, OH.

Industry

Similar private companies

Latest Beam news

Beam Global to Release 2025 Operating Results, Conference Call Scheduled for April 09, 2026 at 4:30 p.m. ET
SAN DIEGO, April 08, 2026 (GLOBE NEWSWIRE) -- Beam Global, (Nasdaq: BEEM), (the 'Company”), a leading provider of innovative and sustainable infrastructure solutions for transportation, energy security and smart city infrastructure, today announced that it will report its 2025 operating results on Thursday, April 09, 2026 after the market closes. Management will host a conference call on Thursday, April 09, 2026 at 4:30 p.m. ET to review financial results and provide an update on corporate developments. Following management’s formal remarks, there will be a question-and-answer session.
The Manila TimesApr 8, 2026
Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU)
New Program Designed as Platform-based Approach for Direct Correction of Mutations Causing PKU; Investigational New Drug (IND) Filing for BEAM‑304 Anticipated in 2026
The Manila TimesFeb 24, 2026
Beam Therapeutics to Host Investor Webcast for Fourth Quarter and Year-End 2025 Financial Results and New Liver-targeted Genetic Disease Program
CAMBRIDGE, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will announce its fourth quarter and full year 2025 financial results and a new liver-targeted genetic disease program on an investor webcast on Tuesday, February 24, 2026, at 8:00 a.m. ET.
The Manila TimesFeb 23, 2026

Talk to a Beam stock specialist

Get personalized guidance on your Beam shares — including current market activity, pricing context, and liquidity options.

Speak with an expert

Frequently asked questions

Is Beam still a private company?
Yes, Beam is currently a private company.
What is Beam's latest funding round?
Beam's most recent known round is Series E.
What is Beam's valuation?
Beam's latest reported valuation is $1B.
Who are the investors in Beam?
Investor information is not currently available.
Can I sell my Beam stock?
Private company shares can sometimes be sold on secondary markets. Speaking with a specialist who understands Beam stock can help you evaluate your options.

Related pages

Last verified: 2026-04-13 · Beam data compiled from funding disclosures, corporate filings, and public records.

Information on this page is compiled from publicly available sources and may be outdated or incomplete. This is not investment advice. Consult a qualified advisor before making financial decisions.